Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
BSX stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Boston Scientific Corporation stock logo

Boston Scientific Corporation

BSX·NYSE

Last updated as of 2026-02-10 18:48 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

BSX stock price change

On the last trading day, BSX stock closed at 74.61 USD, with a price change of 0.66% for the day.
Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

BSX key data

Previous close74.61 USD
Market cap110.65B USD
Volume3.14M
P/E ratio38.47
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)1.94 USD
Net income (FY)2.89B USD
Revenue (FY)20.07B USD
Next report dateApr 29, 2026
EPS estimate0.790 USD
Revenue estimate-
Shares float1.48B
Beta (1Y)0.95
Tokenized stocks

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Boston Scientific Corporation overview

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Sector
Health technology
Industry
Medical Specialties
CEO
Michael F. Mahoney
Headquarters
Marlborough
Website
bostonscientific.com
Founded
1979
Employees (FY)
-
Change (1Y)
-
Revenue / Employee (1Y)
-
Net income / Employee (1Y)
-

BSX Pulse

Daily updates on BSX stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• BSX Stock Price 24h change: -2.82%. From 76.27 USD to 74.12 USD. The decline follows a recent major plunge triggered by slower-than-expected sales in its electrophysiology (EP) division and increased competition in the pulsed field ablation (PFA) market.
• From a technical perspective, the stock is in a "strong bearish" trend, currently trading near its 52-week low of 74.00 USD. The 14-day RSI is approximately 22.36, indicating "oversold" conditions, while the MACD remains negative, suggesting continued downward momentum despite being technically stretched to the downside.
• Law firms have announced securities fraud investigations into Boston Scientific following the 17% stock drop on February 4, 2026, focusing on whether the company misled investors regarding its market dominance and sales projections.
• Analysts from Barclays and Needham have lowered their price targets for BSX to 124.00 USD and 97.00 USD respectively, though they maintain "Buy/Overweight" ratings, citing long-term potential from the Penumbra acquisition.
• Boston Scientific recently set its Q1 2026 EPS guidance at 0.78-0.80 USD, emphasizing a focus on integrating its newly acquired vascular and neurovascular therapeutic areas to offset competitive pressures in the heart rhythm market.
• Healthcare sector news: Philips announced its 2026-2028 targets at its Capital Markets Day, projecting 3%-4.5% sales growth and a focus on AI-integrated hardware to drive margin expansion.
• Healthcare sector news: Global healthcare supply chain inflation is projected to rise by 2.78% through mid-2027, with costs for IT and medical facilities now outpacing pharmacy inflation.
See more
about 7h ago
• BSX Stock Price 24h change: -1.76%. From 77.64 USD to 76.27 USD. The decline was primarily driven by investor reaction to a cautious 2026 outlook that projected slower sales growth and earnings slightly below consensus, despite a Q4 2025 earnings beat.
• From a technical perspective, BSX is currently in a "bearish breakdown" phase. The stock is trading significantly below its 50-day ($93.90) and 200-day ($100.22) moving averages. While the RSI (14) has dipped into oversold territory at 24.14 suggesting a potential short-term bounce, the overall trend remains negative following the recent heavy-volume sell-off.
• Boston Scientific reported Q4 2025 adjusted EPS of $0.80, beating estimates, but its 2026 organic sales growth guidance of 10%-11% marked a significant deceleration from 2025 levels, triggering a sharp stock correction.
• Analysts at Barclays and Stifel lowered their price targets to $124 and $110 respectively, citing concerns over the trajectory of key growth drivers like the Watchman device and the Electrophysiology segment.
• CEO Michael Mahoney sold 160,901 shares on February 2nd at an average price of $93.49, totaling approximately $15 million, which added to the near-term negative market sentiment.
• GE HealthCare announced a collaboration with Diagnoly to integrate AI-powered fetal screening into its ultrasound systems, highlighting the ongoing sector-wide trend toward software-led growth and AI integration in medical imaging.
• The FDA finalized amendments to the Medical Devices Quality System Regulation (QSR) to align with international ISO 13485 standards, aiming to harmonize global regulatory requirements for MedTech manufacturers.
See more
about 1D ago

BSX stock price forecast

According to technical indicators for BSX stock, the price is likely to fluctuate within the range of 73.27–92.54 USD over the next week. Market analysts predict that the price of BSX stock will likely fluctuate within the range of 68.37–118.89 USD over the next months.

Based on 1-year price forecasts from 89 analysts, the highest estimate is 183.70 USD, while the lowest estimate is 84.66 USD.

For more information, please see the BSX stock price forecast Stock Price Forecast page.

Latest BSX stock news

Haemonetics: Fiscal Third Quarter Earnings Overview

101 finance2026-02-05 11:27:30

Spotify steps into the world of physical book retail and introduces enhanced audiobook functionalities

101 finance2026-02-05 12:21:20

BofA Revamps Credit Card Offerings to Drive Bold Consumer Earnings Strategy

101 finance2026-02-05 12:36:41

Acadian Asset Management: Fourth Quarter Financial Overview

101 finance2026-02-05 13:00:16

Amazon and Google are leading the way in AI capital spending — but what is the ultimate reward?

101 finance2026-02-05 23:00:11

AWS revenue continues to soar as cloud demand remains high

101 finance2026-02-05 23:24:19

Analysis-Investors in defense stocks wary as Trump places new limits on CEO pay and dividends

101 finance2026-02-06 11:15:57

Zillow is allowed to move forward with its ban on private listings during its ongoing legal dispute with Compass, according to a federal judge’s decision

101 finance2026-02-06 23:36:31

AI Anxiety Sweeps Wall Street Amidst Emerging Stock Market Landscape

101 finance2026-02-08 15:00:34

Dynatrace: Fiscal Third Quarter Earnings Overview

101 finance2026-02-09 11:42:31

Lidar-maker Ouster buys vision company StereoLabs as sensor consolidation continues

101 finance2026-02-09 20:27:20

What you should understand regarding Netflix’s historic purchase of Warner Bros.

101 finance2026-02-10 16:15:20

What you should understand regarding Netflix’s historic purchase of Warner Bros.

101 finance2026-02-10 16:15:20

Saks Global to close 8 Saks Fifth Avenue stores and 1 Neiman Marcus store in restructuring

101 finance2026-02-10 19:09:31

Rapid7: Fourth Quarter Financial Overview

101 finance2026-02-10 21:30:12

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Boston Scientific Corporation?

BSX is currently priced at 74.61 USD — its price has changed by 0.66% over the past 24 hours. You can track the stock price performance of Boston Scientific Corporation more closely on the price chart at the top of this page.

What is the stock ticker of Boston Scientific Corporation?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Boston Scientific Corporation is traded under the ticker BSX.

What is the stock forecast of BSX?

We've gathered analysts' opinions on Boston Scientific Corporation's future price. According to their forecasts, BSX has a maximum estimate of 746.10 USD and a minimum estimate of 149.22 USD.

What is the market cap of Boston Scientific Corporation?

Boston Scientific Corporation has a market capitalization of 110.65B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
BSX